Item 8.01. Other Events.
On January 7, 2022, Cartica Acquisition Corp (the "Company") completed its
initial public offering (the "IPO") of 23,000,000 units (the "Units"), including
3,000,000 Units sold pursuant to the full exercise of the underwriter's option
to purchase additional units to cover over-allotments, each Unit consisting of
(i) one Class A ordinary share of the Company, par value $0.0001 per share
(collectively, the "Class A Ordinary Shares"), and (ii) one-half of one
redeemable warrant of the Company (collectively, the "Warrants"). Each whole
Warrant entitles the holder thereof to purchase one Class A Ordinary Share for
$11.50 per share. The Units were sold at a price of $10.00 per Unit, generating
gross proceeds to the Company of $230,000,000 (before underwriting discounts and
offering expenses).
Also on January 7, 2022, and simultaneously with the completion of the IPO, the
Company completed the private sale of an aggregate of 15,900,000 warrants (the
"Private Placement Warrants") to the Sponsor at a purchase price of $1.00 per
Private Placement Warrant, generating gross proceeds to the Company of
$15,900,000. The Private Placement Warrants are identical to the Warrants sold
as part of the Units in the IPO, except that the Private Placement Warrants, so
long as they are held by the Sponsor or its permitted transferees, (i) will not
be redeemable by the Company (except as described in the Registration
Statement); (ii) may not (and the Class A ordinary shares issuable upon exercise
of such warrants may not) be transferred, assigned or sold by the holders
thereof until 30 days after the completion of the Company's initial business
combination (subject to certain exceptions described in the Registration
Statement); (iii) may be exercised by the holders thereof on a cashless basis;
and (iv) will be entitled to registration rights. No underwriting discounts or
commissions were paid with respect to such sale. The issuance of the Private
Placement Warrants was made pursuant to the exemption from registration
contained in Section 4(a)(2) of the Securities Act of 1933, as amended.
Also on January 7, 2022, and simultaneously with the completion of the IPO and
the sale of the Private Placement Warrants, a total of $236,900,000 ($10.30 per
Unit), consisting of $225,400,000 of the proceeds from the IPO (which amount
includes $8,050,000 of deferred underwriting commissions) and $11,500,000 of the
proceeds of the sale of the Private Placement Warrants, was placed in a
U.S.-based trust account maintained by Continental Stock Transfer & Trust
Company, acting as trustee.
An audited balance sheet of the Company as of January 7, 2022, reflecting the
Company's receipt of proceeds upon completion of the IPO and the sale of the
Private Placement Warrants, is included as Exhibit 99.1 to this Current Report
on Form 8-K.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
The following exhibits are being filed herewith:
99.1 Audited balance sheet as of January 7, 2022.
2
© Edgar Online, source Glimpses